NCT06268860 - A Study to Assess Bioavailability of Rocatinlimab (AMG 451) Vial and Prefilled Syringe in Healthy Participants | Biotech Hunter

Enrollment

240

Participants

Timeline

Start Date

February 15, 2024

Primary Completion Date

August 30, 2024

Study Completion Date

August 30, 2024

Conditions

Atopic Dermatitis

Interventions

DRUG

Rocatinlimab vial injection

Vial solution for SC injection administered on Day 1

COMBINATION_PRODUCT

Rocatinlimab prefilled syringe

Prefilled syringe solution for SC injection administered on Day 1

Trial Locations (4)

Fortrea Clinical Research Unit - Daytona Beach, Daytona Beach

Fortrea Clinical Research Unit - Dallas, Dallas

Fortrea Clinical Research Unit Inc. - Madison, Madison

Fortrea Clinical Research Unit Limited - Leeds, Leeds